Company / Income Tax per Share
Supernus Pharmaceuticals, Inc. Income Tax per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax per Share
-$0.19
FY2025
5-year range
-$0.19 / $0.44
FY2021-FY2025
Trend
-142.9%
vs FY2024
Sector context
#192 of 201
Health Care
What the data says
Among 201 Health Care companies, Supernus Pharmaceuticals, Inc. is in the top 4% for income tax per share. Income Tax per Share has fluctuated over the past 10 years, ranging from $-0.80 in FY2018 to $0.79 in FY2020.
Based on SEC 10-K filings.
-0.19 in FY2025.
Improved from $0.03 to $-0.19 over the past 2 years.
Health Care sector context is included.
Income Tax per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 4% in Health CareTop 4% of 201This company -$0.19 Sector average $1.35
▼
-113.9% below sector average
Key checks
Key Insights
- In FY2025, income tax per share decreased 142.9% year-over-year.
- Ranks #192 out of 201 companies in the Health Care sector.
- Peak income tax per share was recorded in FY2020.
- Lowest income tax per share in the period was in FY2018.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income Tax per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.19 | -142.9% |
| FY2024 | $0.44 | +1575.8% |
| FY2023 | $0.03 | +4256.5% |
| FY2022 | $0.00 | -99.8% |
| FY2021 | $0.37 | -52.9% |
| FY2020 | $0.79 | +20.6% |
| FY2019 | $0.66 | +182.7% |
| FY2018 | -$0.80 | -6073.3% |
| FY2017 | $0.01 | +3.7% |
| FY2016 | $0.01 | -17.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026